Learning Objective #1: discuss methodological challenges when implementing intervention studies in Hispanic Americans diagnosed with fibromyalgia. | |||
Learning Objective #2: discuss the potential value of mind/body interventions for managing pain and other symptoms related to chronic illness in diverse cultures. |
Purpose: The purpose of this pilot study was to test the effects of a 10-week relaxation and guided imagery intervention on pain, functional status, self-efficacy and distress in Hispanic adults diagnosed with fibromyalgia.
Methods: Quasi-experimental design, pre-post with repeated measures. Participant sample was 15 Hispanic adults with fibromyalgia. The intervention consisted of 3 audiotaped guided imagery scripts used in a proscribed order for 6 weeks and used in any order for weeks 7 through 10. Pain, functional status, self-efficacy and distress were measured baseline, 6- and 10-weeks post-baseline.
Measures: Pain was measured using the Short-Form McGill Pain Questionnaire; functional status, the Fibromyalgia Impact Questionnaire; self-efficacy, the Arthritis Self-Efficacy Scale; distress, the 17-item Mental Health Inventory; and Daily Pain, the Visual Analogue Scale. All instruments were available in English and Spanish.
Findings: The means changed in the expected direction for three of the four dependent variables from baseline to week 10. Changes in self-efficacy for managing pain (10-week, p = 0.02), self-efficacy for managing other symptoms (10-week, p = 0.03), functional status (10-week, p < 0.01), present pain intensity subscale of the SF-MPQ (p = .04), and daily pain (p = 0.03) were significant. Significance p = 0.05.
Discussion: Study findings suggest that we can use relaxation and guided imagery interventions to improve self-efficacy for managing pain and other symptoms related to FM and improve physical functioning in this population. Data from this study will contribute to the further development of nonpharmacologic interventions for pain and other symptom management in minorities with fibromyalgia.